The company, whose repertoire includes arthroscopy equipment, said sales for the third quarter that ended Sept. 30, 2009 were $175.5 million, compared with $179.4 million in the same quarter of 2008.
However, third quarter results “were substantially better than we had anticipated,” said Joseph Corasanti, president and CEO, and represented an $11 million increase over the second quarter.
Read the release on Conmed’s third quarter report.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
